Tighter Part D formularies
Executive Summary
CMS' 2008 Medicare Part D plan bidding methodology appears to be generating more restrictive formularies for low-income members, UnitedHealth Group exec Simon Stevens comments during United's third quarter earnings call Oct. 18. "Some of the low-income members are about to be switched to alternative plans whose drugs the formulary excludes altogether - some of the top branded medicines that their physicians are currently prescribing them," he said. Each year, low-income beneficiaries eligible for Medicare subsidies are automatically assigned by CMS to plans with premiums below a certain benchmark. United may lose up to 650,000 low-income Part D members in 2008 as a result of the bidding process (1"The Pink Sheet" Oct. 1, 2007, p. 12). In response to tightening margins in 2008, United chose to raise its premiums, rather than limit its formularies, Stevens indicates...
You may also be interested in...
Part D Low-Income Enrollee Shifts: United May Lose 650,000 Members In 2008
Next year UnitedHealth Group may lose 650,000 of the auto-assigned low-income members currently enrolled in its stand-alone Medicare prescription drug plans
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.